Enanta Pharmaceuticals, Inc. (ENTA)
12.50
+0.40
(+3.31%)
USD |
NASDAQ |
Oct 09, 16:00
12.48
-0.02
(-0.12%)
After-Hours: 20:00
Enanta Pharmaceuticals Free Cash Flow (Quarterly) : -9.979M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.979M |
| March 31, 2026 | -7.171M |
| December 31, 2025 | -11.84M |
| September 30, 2025 | -7.947M |
| June 30, 2025 | 17.35M |
| March 31, 2025 | -16.03M |
| December 31, 2024 | -25.55M |
| September 30, 2024 | -19.35M |
| June 30, 2024 | -21.32M |
| March 31, 2024 | -30.27M |
| December 31, 2023 | -25.78M |
| September 30, 2023 | -22.97M |
| June 30, 2023 | -34.28M |
| March 31, 2023 | -16.17M |
| December 31, 2022 | -38.80M |
| September 30, 2022 | -16.97M |
| June 30, 2022 | -29.85M |
| March 31, 2022 | -26.45M |
| December 31, 2021 | -13.63M |
| September 30, 2021 | -21.05M |
| June 30, 2021 | -29.90M |
| March 31, 2021 | -4.709M |
| December 31, 2020 | -15.08M |
| September 30, 2020 | -15.79M |
| June 30, 2020 | -4.761M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.32M |
| December 31, 2019 | 11.88M |
| September 30, 2019 | 8.249M |
| June 30, 2019 | 0.303M |
| March 31, 2019 | 27.58M |
| December 31, 2018 | 29.87M |
| September 30, 2018 | 27.72M |
| June 30, 2018 | 2.946M |
| March 31, 2018 | -8.33M |
| December 31, 2017 | 3.905M |
| September 30, 2017 | 57.07M |
| June 30, 2017 | -5.537M |
| March 31, 2017 | -3.58M |
| December 31, 2016 | 2.192M |
| September 30, 2016 | -2.541M |
| June 30, 2016 | -2.725M |
| March 31, 2016 | 8.541M |
| December 31, 2015 | 27.80M |
| September 30, 2015 | -3.955M |
| June 30, 2015 | -14.60M |
| March 31, 2015 | 98.76M |
| December 31, 2014 | -5.866M |
| September 30, 2014 | -5.417M |
| June 30, 2014 | 34.73M |
| March 31, 2014 | -4.271M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -34.87M |
| Coherus Oncology, Inc. | -62.09M |
| BridgeBio Pharma, Inc. | -71.54M |
| RenovoRx, Inc. | -2.938M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |